Claims for Patent: 6,623,731

Summary for Patent: 6,623,731

Title:	Compounds and compositions for delivering active agents
Abstract:	Modified amino acid compounds useful in the delivery of active agents are provided. The active agents can be peptides, such as rhGH. Methods of administration, such as oral, subcutaneous, sublingual, and intranasal administration, are provided, and methods of preparation of the modified amino acid compound are provided.
Inventor(s):	Leone-Bay; Andrea (Ridgefield, CT), Ho; Koc-Kan (Monmouth Junction, NJ), Sarubbi; Donald J. (Carmel, NY), Milstein; Sam J. (Larchmont, NY)
Assignee:	Emisphere Technologies, Inc. (Tarrytown, NY)
Application Number:	10/038,426
Patent Claims:	1. A composition comprising: (A) at least one active agent; and (B) a compound having the following formula ##STR67## or a salt thereof. 2. A composition as defined in claim 1, wherein said active agent is selected from the group consisting of a biologically active agent, a chemically active agent, and a combination thereof. 3. A composition as defined in claim 2, wherein said biologically active agent comprises at least one peptide, hormone, polysaccharide, mucopolysaceharide, carbohydrate, or lipid. 4. The composition as defined in claim 3, wherein said biologically active agent is selected from the group consisting of human growth hormone, bovine growth hormone, growth hormone-releasing hormone, an interferon, interleukin-1, interleukin-II, insulin, heparin, low molecular weight heparin, calcitonin, erythropoietin, atrial naturetic factor, an antigen, a monoclonal antibody, somatostatin, adrenocorticotropin, gonadotropin releasing hormone, oxytocin, vasopressin, cromolyn sodium, vancomycin, parathyroid hormone, desferrioxamine, an anti-microbial agent, an anti-fungal agent, and any combination thereof. 5. A composition as defined in claim 4, wherein said biologically active agent comprises an interferon, interleukin-II, insulin, heparin, low molecular weight heparin, calcitonin, oxytocin, vasopressin, vancomycin, DFO, parathyroid hormone, or a combination thereof. 6. A composition as defined in claim 2, wherein said biologically active agent comprises parathyroid hormone. 7. A composition as defined in claim 2, wherein said biologically active agent comprises recombinant human growth hormone. 8. A composition as defined on claim 2, wherein said biologically active agent comprises interferon. 9. A composition as defined in claim 2, wherein said biologically active agent comprises heparin. 10. A composition as defined in claim 2, wherein said biologically active agent comprises low molecular weight heparin. 11. A composition as defined in claim 1, wherein said compound comprises a poly(amino acid). 12. A composition as defined in claim 1, wherein said compound comprises a polypeptide. 13. A dosage unit form comprising: (A) a composition as defined in claim 1; and (B) (a) an excipient (b) a diluent, (c) a disintegrant, (d) a lubricant, (e) a plasticizer, (f) a colorant, (g) a dosing vehicle, or (h) any combination thereof. 14. The dosage unit form as defined in claim 13, wherein said active agent is selected from the group consisting of a biologically active agent, a chemically active agent, and a combination thereof. 15. The dosage unit form as defined in claim 14, wherein said biologically active agent comprises at least one peptide, hormone, polysaceharide, mucopolysaccharide, carbohydrate, or lipid. 16. The dosage unit form as defined in claim 15, wherein said biologically active agent is selected from the group consisting of human growth hormone, bovine growth hormone, growth hormone-releasing hormone, an interferon, interleukin-1, interleukin-II, insulin, heparin, low molecular weight heparin, calcitonin, erythropoietin, atrial naturetic factor, an antigen, a monoclonal antibody, somatostatin, adrenocorticotropin, gonadotropin releasing hormone, oxytocin, vasopressin, cromolyn sodium, vaneomycin, parathyroid hormone, desferrioxamine, an anti-microbial agent, an anti-fungal agent, and any combination thereof. 17. A dosage unit form as defined in claim 16, wherein said biologically active agent comprises an interferon, interleukin-II, insulin, heparin, low molecular weight heparin, calcitonin, oxytocin, vasopressin, vancomycin, DFO, parathyroid hormone, or a combination thereof. 18. A dosage unit form as defined in claim 14, wherein said biologically active agent comprises parathyroid hormone. 19. A dosage unit form as defined in claim 14, wherein said biologically active agent comprises recombinant human growth hormone. 20. A dosage unit form as defined on claim 14, wherein said biologically active agent comprises interferon. 21. A dosage unit form as defined in claim 14, wherein said biologically active agent comprises heparin. 22. A dosage unit form as defined in claim 14, wherein said biologically active agent comprises low molecular weight heparin. 23. A dosage unit form as defined in claim 13, comprising a tablet, a capsule, or a liquid. 24. A dosage unit form as defined in claim 23, wherein said dosing vehicle is selected from the group consisting of water, 1,2-propane diol, ethanol, and any combination thereof. 25. A method for administering a biologically-active agent to an animal in need of said agent, said method comprising administering orally to said animal a composition as defined in claim 2. 26. A compound having the formula ##STR68## or a salt thereof. 27. A method for preparing a composition, said method comprising mixing: (A) at least one active agent; (B) at least one compound as defined in claim 26; and (C) optionally, a dosing vehicle. 28. A composition comprising: (A) at least one active agent; and (B) a poly(amino acid) comprising a monomer having the formula ##STR69## or a salt thereof. 29. A composition as defined in claim 28, wherein the poly(amino acid) comprises a peptide.

Details for Patent 6,623,731

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2015-03-31